Stone Warren bought NEO
February 21, 2026 · Form 4 insider transaction
Stone Warren bought 28,105 shares of NeoGenomics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
28,105
Price
$0.00
Total value
N/A
InsiderStone Warren
Role—
CompanyNeoGenomics, Inc. (NEO)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 21, 2026
Filing dateFebruary 24, 2026
Shares owned after149,736
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.